<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37784134</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1478-6362</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Arthritis research &amp; therapy</Title><ISOAbbreviation>Arthritis Res Ther</ISOAbbreviation></Journal><ArticleTitle>M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics.</ArticleTitle><Pagination><StartPage>189</StartPage><MedlinePgn>189</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">189</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13075-023-03149-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">N6-methyladenosine (m6A) methylation modification is involved in the regulation of various biological processes, including inflammation, antitumor, and antiviral immunity. However, the role of m6A modification in the pathogenesis of autoimmune diseases has been rarely reported.</AbstractText><AbstractText Label="METHODS">Based on a description of m6A modification and the corresponding research methods, this review systematically summarizes current insights into the mechanism of m6A methylation modification in autoimmune diseases, especially its contribution to rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).</AbstractText><AbstractText Label="RESULTS">By regulating different biological processes, m6A methylation is involved in the pathogenesis of autoimmune diseases and provides a promising biomarker for the diagnosis and treatment of such diseases. Notably, m6A methylation modification is involved in regulating a variety of immune cells and mitochondrial energy metabolism. In addition, m6A methylation modification plays a role in the pathological processes of RA, and m6A methylation-related genes can be used as potential targets in RA therapy.</AbstractText><AbstractText Label="CONCLUSIONS">M6A methylation modification plays an important role in autoimmune pathological processes such as RA and SLE and represents a promising new target for clinical diagnosis and treatment, providing new ideas for the treatment of autoimmune diseases by targeting m6A modification-related pathways.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Yurong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, No. 1 Qianjiang Road, Xinzhan District, Hefei, 230012, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xue</LastName><ForeName>Qiuyun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, No. 1 Qianjiang Road, Xinzhan District, Hefei, 230012, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, the First Affiliated Hospital, Anhui Medical University, Hefei, 230032, China. changjun_2008@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Public Health Clinical Center, Hefei, China. changjun_2008@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, No. 1 Qianjiang Road, Xinzhan District, Hefei, 230012, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Chenglong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, No. 1 Qianjiang Road, Xinzhan District, Hefei, 230012, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Suowen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China, Hefei, 230027, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Nursing, School of Nursing, Anhui University of Chinese Medicine, Hefei, China. wangxiao@ahtcm.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Chenggui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, No. 1 Qianjiang Road, Xinzhan District, Hefei, 230012, Anhui Province, China. miaocg@ahtcm.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arthritis Res Ther</MedlineTA><NlmUniqueID>101154438</NlmUniqueID><ISSNLinking>1478-6354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008745" MajorTopicYN="N">Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmune diseases</Keyword><Keyword MajorTopicYN="N">Methylation regulation</Keyword><Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">m6a methylation modification</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>3</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>23</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37784134</ArticleId><ArticleId IdType="pmc">PMC10544321</ArticleId><ArticleId IdType="doi">10.1186/s13075-023-03149-w</ArticleId><ArticleId IdType="pii">10.1186/s13075-023-03149-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vu LP, Cheng Y, Kharas MG. The biology of m6A RNA methylation in normal and malignant hematopoiesis. Cancer Discov. 2019;9(1):25&#x2013;33. doi: 10.1158/2159-8290.CD-18-0959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-18-0959</ArticleId><ArticleId IdType="pubmed">30578356</ArticleId></ArticleIdList></Reference><Reference><Citation>Roundtree IA, Evans ME, Pan T, et al. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169(7):1187&#x2013;1200. doi: 10.1016/j.cell.2017.05.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.045</ArticleId><ArticleId IdType="pmc">PMC5657247</ArticleId><ArticleId IdType="pubmed">28622506</ArticleId></ArticleIdList></Reference><Reference><Citation>Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci U S A. 1974;71(10):3971&#x2013;3975. doi: 10.1073/pnas.71.10.3971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.71.10.3971</ArticleId><ArticleId IdType="pmc">PMC434308</ArticleId><ArticleId IdType="pubmed">4372599</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;fer KP. RNA synthesis and processing reactions in a subcellular system from mouse L cells. Hoppe Seylers Z Physiol Chem. 1982;363(1):33&#x2013;43. doi: 10.1515/bchm2.1982.363.1.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/bchm2.1982.363.1.33</ArticleId><ArticleId IdType="pubmed">6174404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipshitz HD, Claycomb JM, Smibert CA. Post-transcriptional regulation of gene expression. Methods. 2017;126:1&#x2013;2. doi: 10.1016/j.ymeth.2017.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2017.08.007</ArticleId><ArticleId IdType="pubmed">28867174</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H, Wang X, Lu Z, et al. YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. Cell Res. 2017;27(3):315&#x2013;328. doi: 10.1038/cr.2017.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2017.15</ArticleId><ArticleId IdType="pmc">PMC5339834</ArticleId><ArticleId IdType="pubmed">28106072</ArticleId></ArticleIdList></Reference><Reference><Citation>Roignant JY, Soller M. m6A in mRNA: an ancient mechanism for fine-tuning gene expression. Trends Genet. 2017;33(6):380&#x2013;390. doi: 10.1016/j.tig.2017.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2017.04.003</ArticleId><ArticleId IdType="pubmed">28499622</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert WV, Bell TA, Schaening C. Messenger RNA modifications: form, distribution, and function. Science. 2016;352(6292):1408&#x2013;1412. doi: 10.1126/science.aad8711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad8711</ArticleId><ArticleId IdType="pmc">PMC5094196</ArticleId><ArticleId IdType="pubmed">27313037</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardowska A. m6A RNA Methylation in Systemic Autoimmune Diseases-A New Target for Epigenetic-Based Therapy? Pharmaceuticals (Basel) 2021;14(3):218. doi: 10.3390/ph14030218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14030218</ArticleId><ArticleId IdType="pmc">PMC8001529</ArticleId><ArticleId IdType="pubmed">33807762</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Yang Z, Li R, et al. Potential roles of N6-methyladenosine (m6A) in immune cells. J Transl Med. 2021;19(1):251. doi: 10.1186/s12967-021-02918-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02918-y</ArticleId><ArticleId IdType="pmc">PMC8186046</ArticleId><ArticleId IdType="pubmed">34103054</ArticleId></ArticleIdList></Reference><Reference><Citation>Juarranz Y. Molecular and cellular basis of autoimmune diseases. Cells. 2021;10(2):474. doi: 10.3390/cells10020474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020474</ArticleId><ArticleId IdType="pmc">PMC7926515</ArticleId><ArticleId IdType="pubmed">33672111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhernakova A, Withoff S, Wijmenga C. Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat Rev Endocrinol. 2013;9(11):646&#x2013;659. doi: 10.1038/nrendo.2013.161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2013.161</ArticleId><ArticleId IdType="pubmed">23959365</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslani S, Mahmoudi M, Karami J, et al. Epigenetic alterations underlying autoimmune diseases. Autoimmunity. 2016;49(2):69&#x2013;83. doi: 10.3109/08916934.2015.1134511.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2015.1134511</ArticleId><ArticleId IdType="pubmed">26761426</ArticleId></ArticleIdList></Reference><Reference><Citation>Frazzei G, van Vollenhoven RF, de Jong BA, et al. Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes. Front Immunol. 2022;13:899372. doi: 10.3389/fimmu.2022.899372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.899372</ArticleId><ArticleId IdType="pmc">PMC9281565</ArticleId><ArticleId IdType="pubmed">35844538</ArticleId></ArticleIdList></Reference><Reference><Citation>You R, He X, Zeng Z, et al. Pyroptosis and its role in autoimmune disease: a potential therapeutic target. Front Immunol. 2022;13:841732. doi: 10.3389/fimmu.2022.841732.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.841732</ArticleId><ArticleId IdType="pmc">PMC9174462</ArticleId><ArticleId IdType="pubmed">35693810</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094&#x2013;1108. doi: 10.1016/S0140-6736(10)60826-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60826-4</ArticleId><ArticleId IdType="pubmed">20870100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YJ, Anzaghe M, Sch&#xfc;lke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020;9(4):880. doi: 10.3390/cells9040880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040880</ArticleId><ArticleId IdType="pmc">PMC7226834</ArticleId><ArticleId IdType="pubmed">32260219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol. 2015;11(6):329&#x2013;341. doi: 10.1038/nrneph.2015.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2015.33</ArticleId><ArticleId IdType="pubmed">25825084</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Nagafuchi Y, Fujio K. Clinical and immunological biomarkers for systemic lupus erythematosus. Biomolecules. 2021;11(7):928. doi: 10.3390/biom11070928.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11070928</ArticleId><ArticleId IdType="pmc">PMC8301935</ArticleId><ArticleId IdType="pubmed">34206696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kami&#x144;ska J, Koper OM, Piechal K, et al. Multiple sclerosis - etiology and diagnostic potential. Postepy Hig Med Dosw (Online) 2017;71:551&#x2013;563. doi: 10.5604/01.3001.0010.3836.</Citation><ArticleIdList><ArticleId IdType="doi">10.5604/01.3001.0010.3836</ArticleId><ArticleId IdType="pubmed">28665284</ArticleId></ArticleIdList></Reference><Reference><Citation>Careta MF, Romiti R. Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol. 2015;90(1):62&#x2013;73. doi: 10.1590/abd1806-4841.20152890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/abd1806-4841.20152890</ArticleId><ArticleId IdType="pmc">PMC4323700</ArticleId><ArticleId IdType="pubmed">25672301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ, Li CW, Hammerstad SS, et al. Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J Autoimmun. 2015;64:82&#x2013;90. doi: 10.1016/j.jaut.2015.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.07.009</ArticleId><ArticleId IdType="pmc">PMC4628844</ArticleId><ArticleId IdType="pubmed">26235382</ArticleId></ArticleIdList></Reference><Reference><Citation>DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391(10138):2449&#x2013;2462. doi: 10.1016/S0140-6736(18)31320-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)31320-5</ArticleId><ArticleId IdType="pmc">PMC6661119</ArticleId><ArticleId IdType="pubmed">29916386</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrini S, Emmi G, Greco M, et al. Sj&#xf6;gren's syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22(1):9&#x2013;25. doi: 10.1007/s10238-021-00728-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-021-00728-6</ArticleId><ArticleId IdType="pmc">PMC8863725</ArticleId><ArticleId IdType="pubmed">34100160</ArticleId></ArticleIdList></Reference><Reference><Citation>Glissen Brown JR, Singh P. Coeliac disease. Paediatr Int Child Health. 2019;39(1):23&#x2013;31. doi: 10.1080/20469047.2018.1504431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20469047.2018.1504431</ArticleId><ArticleId IdType="pubmed">30099930</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2&#x2013;16. doi: 10.1080/09273948.2016.1196713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2016.1196713</ArticleId><ArticleId IdType="pubmed">27467180</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74(4):640&#x2013;650. doi: 10.1016/j.molcel.2019.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.04.025</ArticleId><ArticleId IdType="pmc">PMC6527355</ArticleId><ArticleId IdType="pubmed">31100245</ArticleId></ArticleIdList></Reference><Reference><Citation>Oerum S, Meynier V, Catala M, et al. A comprehensive review of m6A/m6Am RNA methyltransferase structures. Nucleic Acids Res. 2021;49(13):7239&#x2013;7255. doi: 10.1093/nar/gkab378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab378</ArticleId><ArticleId IdType="pmc">PMC8287941</ArticleId><ArticleId IdType="pubmed">34023900</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Hsu PJ, Chen YS, et al. Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28(6):616&#x2013;624. doi: 10.1038/s41422-018-0040-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-018-0040-8</ArticleId><ArticleId IdType="pmc">PMC5993786</ArticleId><ArticleId IdType="pubmed">29789545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Fu J, Zhou Y. A review in research progress concerning m6A methylation and immunoregulation. Front Immunol. 2019;10:922. doi: 10.3389/fimmu.2019.00922.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00922</ArticleId><ArticleId IdType="pmc">PMC6497756</ArticleId><ArticleId IdType="pubmed">31080453</ArticleId></ArticleIdList></Reference><Reference><Citation>Paramasivam A, Priyadharsini JV, Raghunandhakumar S. Implications of m6A modification in autoimmune disorders. Cell Mol Immunol. 2020;17(5):550&#x2013;551. doi: 10.1038/s41423-019-0307-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-019-0307-0</ArticleId><ArticleId IdType="pmc">PMC7192904</ArticleId><ArticleId IdType="pubmed">31649306</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Campos MA, Edelheit S, Toth U, et al. Deciphering the "m6A Code" via antibody-independent quantitative profiling. Cell. 2019;178(3):731&#x2013;747.e16. doi: 10.1016/j.cell.2019.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.06.013</ArticleId><ArticleId IdType="pubmed">31257032</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer KD. DART-seq: an antibody-free method for global m6A detection. Nat Methods. 2019;16(12):1275&#x2013;1280. doi: 10.1038/s41592-019-0570-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0570-0</ArticleId><ArticleId IdType="pmc">PMC6884681</ArticleId><ArticleId IdType="pubmed">31548708</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XF, Sun YY, Bao J, et al. Functional role of PPAR-&#x3b3; on the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis. Sci Rep. 2017;7(1):12671. doi: 10.1038/s41598-017-12570-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-12570-6</ArticleId><ArticleId IdType="pmc">PMC5627284</ArticleId><ArticleId IdType="pubmed">28978936</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Wang X, Guo X, et al. Integrative analysis of genome-wide association study and expression quantitative trait loci datasets identified various immune cell-related pathways for rheumatoid arthritis. Ann Hum Genet. 2020;84(1):72&#x2013;79. doi: 10.1111/ahg.12351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ahg.12351</ArticleId><ArticleId IdType="pubmed">31486066</ArticleId></ArticleIdList></Reference><Reference><Citation>Pap T, Dankbar B, Wehmeyer C, et al. Synovial fibroblasts and articular tissue remodelling: role and mechanisms. Semin Cell Dev Biol. 2020;101:140&#x2013;145. doi: 10.1016/j.semcdb.2019.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.12.006</ArticleId><ArticleId IdType="pubmed">31956018</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Cai X, Wang R, et al. Identification of synovial fibroblast-associated neuropeptide genes and m6A factors in rheumatoid arthritis using single-cell analysis and machine learning. Dis Markers. 2022;2022:5114697. doi: 10.1155/2022/5114697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/5114697</ArticleId><ArticleId IdType="pmc">PMC8849968</ArticleId><ArticleId IdType="pubmed">35186167</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng Q, Cao X, Fan D, et al. Diagnostic gene signatures and aberrant pathway activation based on m6A methylation regulators in rheumatoid arthritis. Front Immunol. 2022;13:1041284. doi: 10.3389/fimmu.2022.1041284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1041284</ArticleId><ArticleId IdType="pmc">PMC9793088</ArticleId><ArticleId IdType="pubmed">36582238</ArticleId></ArticleIdList></Reference><Reference><Citation>Song YJ, Li G, He JH, et al. Bioinformatics-based identification of microRNA-regulated and rheumatoid arthritis-associated genes. PLoS One. 2015;10(9):e0137551. doi: 10.1371/journal.pone.0137551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0137551</ArticleId><ArticleId IdType="pmc">PMC4567271</ArticleId><ArticleId IdType="pubmed">26359667</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Li R, Xu S, et al. SMOC2 promotes aggressive behavior of fibroblast-like synoviocytes in rheumatoid arthritis through transcriptional and post-transcriptional regulating MYO1C. Cell Death Dis. 2022;13(12):1035. doi: 10.1038/s41419-022-05479-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-05479-0</ArticleId><ArticleId IdType="pmc">PMC9747908</ArticleId><ArticleId IdType="pubmed">36513634</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Hu X, Huang M, et al. Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation. Nat Commun. 2019;10(1):1898. doi: 10.1038/s41467-019-09903-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09903-6</ArticleId><ArticleId IdType="pmc">PMC6478715</ArticleId><ArticleId IdType="pubmed">31015515</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Yan S, Lu H, et al. METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-&#x3ba;B Signaling Pathway. Mediators Inflamm. 2019;2019:3120391. doi: 10.1155/2019/3120391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/3120391</ArticleId><ArticleId IdType="pmc">PMC6854952</ArticleId><ArticleId IdType="pubmed">31772500</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W, Zheng Y, Luo S, et al. METTL3 promotes activation and inflammation of FLSs through the NF-&#x3ba;B signaling pathway in rheumatoid arthritis. Front Med (Lausanne). 2021;8:607585. doi: 10.3389/fmed.2021.607585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.607585</ArticleId><ArticleId IdType="pmc">PMC8290917</ArticleId><ArticleId IdType="pubmed">34295905</ArticleId></ArticleIdList></Reference><Reference><Citation>Katschke KJ, Jr, Rottman JB, Ruth JH, et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 2001;44(5):1022&#x2013;1032. doi: 10.1002/1529-0131(200105)44:5&lt;1022::AID-ANR181&gt;3.0.CO;2-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200105)44:5&lt;1022::AID-ANR181&gt;3.0.CO;2-N</ArticleId><ArticleId IdType="pubmed">11352233</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Li X, Jia H, et al. The m6A methyltransferase METTL3 modifies PGC-1&#x3b1; mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes. J Biol Chem. 2021;297(3):101058. doi: 10.1016/j.jbc.2021.101058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101058</ArticleId><ArticleId IdType="pmc">PMC8406003</ArticleId><ArticleId IdType="pubmed">34375639</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Li H, Liu Y, et al. Epigenetic regulation of immune and inflammatory responses in rheumatoid arthritis. Front Immunol. 2022;13:881191. doi: 10.3389/fimmu.2022.881191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.881191</ArticleId><ArticleId IdType="pmc">PMC9035598</ArticleId><ArticleId IdType="pubmed">35479077</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L, Liu J, Huang C, et al. Comprehensive analysis and functional characteristics of differential expression of N6-Methyladenosine methylation modification in the whole transcriptome of rheumatoid arthritis. Mediators Inflamm. 2022;25(2022):4766992. doi: 10.1155/2022/4766992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/4766992</ArticleId><ArticleId IdType="pmc">PMC9626244</ArticleId><ArticleId IdType="pubmed">36330380</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Xu K, Saaoud F, et al. 29 m6A-RNA methylation (Epitranscriptomic) regulators are regulated in 41 diseases including atherosclerosis and tumors potentially via ROS Regulation - 102 Transcriptomic Dataset Analyses. J Immunol Res. 2022;2022:1433323. doi: 10.1155/2022/1433323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/1433323</ArticleId><ArticleId IdType="pmc">PMC8863469</ArticleId><ArticleId IdType="pubmed">35211628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorci M, Ianniello Z, Cruciani S, et al. METTL3 regulates WTAP protein homeostasis. Cell Death Dis. 2018;9(8):796. doi: 10.1038/s41419-018-0843-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0843-z</ArticleId><ArticleId IdType="pmc">PMC6056540</ArticleId><ArticleId IdType="pubmed">30038300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor A, Fan YH, Arav-Boger R. Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-&#x3b2;-Dependent Pathway. Sci Rep. 2016;6:20295. doi: 10.1038/srep20295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20295</ArticleId><ArticleId IdType="pmc">PMC4735818</ArticleId><ArticleId IdType="pubmed">26830977</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Qiu Y, Hao Z, et al. A novel humanized anti-tumor necrosis factor-related apoptosis-inducing ligand-R2 monoclonal antibody induces apoptotic and autophagic cell death. IUBMB Life. 2017;69(9):735&#x2013;744. doi: 10.1002/iub.1659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1659</ArticleId><ArticleId IdType="pubmed">28748573</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Cao K, Fan C, et al. Transcriptome-Wide High-Throughput m6A Sequencing of Differential m6A Methylation Patterns in the Human Rheumatoid Arthritis Fibroblast-Like Synoviocytes Cell Line MH7A. J Inflamm Res. 2021;14:575&#x2013;586. doi: 10.2147/JIR.S296006.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S296006</ArticleId><ArticleId IdType="pmc">PMC7920605</ArticleId><ArticleId IdType="pubmed">33658830</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao F, Xu C, Gao Y, et al. Expression and clinical significance of the m6A reader YTHDF2 in peripheral blood mononuclear cells from rheumatoid arthritis patients. J Immunotoxicol. 2022;19(1):53&#x2013;60. doi: 10.1080/1547691X.2022.2067916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1547691X.2022.2067916</ArticleId><ArticleId IdType="pubmed">35776431</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Q, Gao Y, Zhang L, et al. Decreased ALKBH5, FTO, and YTHDF2 in peripheral blood are as risk factors for rheumatoid arthritis. Biomed Res Int. 2020;2020:5735279. doi: 10.1155/2020/5735279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5735279</ArticleId><ArticleId IdType="pmc">PMC7455827</ArticleId><ArticleId IdType="pubmed">32884942</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L, Liu J, Huang C, et al. Role of m6A modification and novel circ_0066715/ miR-486-5p/ ETS1 axis in rheumatoid arthritis macrophage polarization progression. Aging (Albany NY) 2022;14(24):10009&#x2013;10026. doi: 10.18632/aging.204439.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.204439</ArticleId><ArticleId IdType="pmc">PMC9831719</ArticleId><ArticleId IdType="pubmed">36541909</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancarella C, Scotlandi K. IGF2BP3 from physiology to cancer: novel discoveries, unsolved issues, and future perspectives. Front Cell Dev Biol. 2020;7:363. doi: 10.3389/fcell.2019.00363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00363</ArticleId><ArticleId IdType="pmc">PMC6974587</ArticleId><ArticleId IdType="pubmed">32010687</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabucchi M, Mategot R. Subcellular heterogeneity of the microRNA machinery. Trends Genet. 2019;35(1):15&#x2013;28. doi: 10.1016/j.tig.2018.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.10.006</ArticleId><ArticleId IdType="pubmed">30503571</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Mao X, Li W, et al. Tripterygium wilfordii: an inspiring resource for rheumatoid arthritis treatment. Med Res Rev. 2021;41(3):1337&#x2013;1374. doi: 10.1002/med.21762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21762</ArticleId><ArticleId IdType="pubmed">33296090</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan D, Liu B, Gu X, et al. Potential target analysis of triptolide based on transcriptome-wide m6A methylome in rheumatoid arthritis. Front Pharmacol. 2022;13:843358. doi: 10.3389/fphar.2022.843358.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.843358</ArticleId><ArticleId IdType="pmc">PMC8993230</ArticleId><ArticleId IdType="pubmed">35401168</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Y, Liu P, Wen W, et al. Sarsasapogenin, a principal active component absorbed into blood of total saponins of Anemarrhena, attenuates proliferation and invasion in rheumatoid arthritis fibroblast-like synoviocytes through downregulating PKM2 inhibited pathological glycolysis. Phytother Res. 2023;37(5):1951&#x2013;1967. doi: 10.1002/ptr.7712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.7712</ArticleId><ArticleId IdType="pubmed">36631974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Tao C, Zhang R, et al. N6-methyladenosine modification of TGM2 mRNA contributes to the inhibitory activity of sarsasapogenin in rheumatoid arthritis fibroblast-like synoviocytes. Phytomedicine. 2022;95:153871. doi: 10.1016/j.phymed.2021.153871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2021.153871</ArticleId><ArticleId IdType="pubmed">34902811</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC, Lo MS, Costa Reis P, et al. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716&#x2013;730. doi: 10.1038/nrrheum.2016.186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.186</ArticleId><ArticleId IdType="pubmed">27872476</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Q, Fu B, Zhang L, et al. Decreased peripheral blood ALKBH5 correlates with markers of autoimmune response in systemic lupus erythematosus. Dis Markers. 2020;2020:8193895. doi: 10.1155/2020/8193895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/8193895</ArticleId><ArticleId IdType="pmc">PMC7334764</ArticleId><ArticleId IdType="pubmed">32685056</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Q, Rao J, Zhang L, et al. The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus. Mol Genet Genomic Med. 2020;8(9):e1298. doi: 10.1002/mgg3.1298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mgg3.1298</ArticleId><ArticleId IdType="pmc">PMC7507441</ArticleId><ArticleId IdType="pubmed">32583611</ArticleId></ArticleIdList></Reference><Reference><Citation>Oster C, Wilde B, Specker C, et al. BTLA expression on Th1, Th2 and Th17 effector T-Cells of patients with systemic lupus erythematosus is associated with active disease. Int J Mol Sci. 2019;20(18):4505. doi: 10.3390/ijms20184505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184505</ArticleId><ArticleId IdType="pmc">PMC6770819</ArticleId><ArticleId IdType="pubmed">31514450</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng LJ, Fang XY, Wu J, et al. ALKBH5 expression could affect the function of T cells in systemic lupus erythematosus patients: a case-control study. Curr Pharm Des. 2022;28(27):2270&#x2013;2278. doi: 10.2174/1381612828666220617154204.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612828666220617154204</ArticleId><ArticleId IdType="pubmed">35718974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Ge L, Wang J, et al. Exploration of potential integrated models of n6-methyladenosine immunity in systemic lupus erythematosus by bioinformatic analyses. Front Immunol. 2022;12:752736. doi: 10.3389/fimmu.2021.752736.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.752736</ArticleId><ArticleId IdType="pmc">PMC8859446</ArticleId><ArticleId IdType="pubmed">35197962</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo G, Wang H, Shi X, et al. Disease activity-associated alteration of mRNA m5 C methylation in CD4+ T cells of systemic lupus erythematosus. Front Cell Dev Biol. 2020;8:430. doi: 10.3389/fcell.2020.00430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00430</ArticleId><ArticleId IdType="pmc">PMC7291606</ArticleId><ArticleId IdType="pubmed">32582707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Deng LJ, Xia YR, et al. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus. Mol Immunol. 2022;143:77&#x2013;84. doi: 10.1016/j.molimm.2022.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2022.01.006</ArticleId><ArticleId IdType="pubmed">35051888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Dong R, Zhang L, et al. N6-methyladenosine-dependent modification of circGARS acts as a new player that promotes SLE progression through the NF-&#x3ba;B/A20 axis. Arthritis Res Ther. 2022;24(1):37. doi: 10.1186/s13075-022-02732-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-022-02732-x</ArticleId><ArticleId IdType="pmc">PMC8815128</ArticleId><ArticleId IdType="pubmed">35120571</ArticleId></ArticleIdList></Reference><Reference><Citation>Imgenberg-Kreuz J, Rasmussen A, Sivils K, et al. Genetics and epigenetics in primary Sj&#xf6;gren&#x2019;s syndrome. Rheumatology (Oxford) 2021;60(5):2085&#x2013;2098. doi: 10.1093/rheumatology/key330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/key330</ArticleId><ArticleId IdType="pmc">PMC8121440</ArticleId><ArticleId IdType="pubmed">30770922</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q, Wu X, Deng C, et al. The potential role of RNA N6-methyladenosine in primary Sj&#xf6;gren's syndrome. Front Med (Lausanne) 2022;9:959388. doi: 10.3389/fmed.2022.959388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.959388</ArticleId><ArticleId IdType="pmc">PMC9710536</ArticleId><ArticleId IdType="pubmed">36465909</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Liu H, Yu C. N6-Methyladenosine regulator-mediated RNA methylation is involved in primary Sj&#xf6;gren&#x2019;s syndrome immunoinfiltration. Dis Markers. 2022;2022:5242287. doi: 10.1155/2022/5242287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/5242287</ArticleId><ArticleId IdType="pmc">PMC9708334</ArticleId><ArticleId IdType="pubmed">36457545</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L, Li H, Zhan H, et al. Alterations of m6A RNA methylation regulators contribute to autophagy and immune infiltration in primary Sj&#xf6;gren's syndrome. Front Immunol. 2022;13:949206. doi: 10.3389/fimmu.2022.949206.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.949206</ArticleId><ArticleId IdType="pmc">PMC9530814</ArticleId><ArticleId IdType="pubmed">36203590</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Zhao BS, Zhou A, et al. m6A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell. 2017;31(4):591&#x2013;606.e6. doi: 10.1016/j.ccell.2017.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2017.02.013</ArticleId><ArticleId IdType="pmc">PMC5427719</ArticleId><ArticleId IdType="pubmed">28344040</ArticleId></ArticleIdList></Reference><Reference><Citation>Song RH, Zhao J, Gao CQ, et al. Inclusion of ALKBH5 as a candidate gene for the susceptibility of autoimmune thyroid disease. Adv Med Sci. 2021;66(2):351&#x2013;358. doi: 10.1016/j.advms.2021.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.advms.2021.07.006</ArticleId><ArticleId IdType="pubmed">34304114</ArticleId></ArticleIdList></Reference><Reference><Citation>Song RH, Liu XR, Gao CQ, et al. METTL3 gene polymorphisms contribute to susceptibility to autoimmune thyroid disease. Endocrine. 2021;72(2):495&#x2013;504. doi: 10.1007/s12020-020-02503-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02503-1</ArticleId><ArticleId IdType="pubmed">33025559</ArticleId></ArticleIdList></Reference><Reference><Citation>Subekti I, Pramono LA. Current diagnosis and management of Graves' disease. Acta Med Indones. 2018;50(2):177&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">29950539</ArticleId></ArticleIdList></Reference><Reference><Citation>Song RH, Du P, Gao CQ, et al. METTL3 is involved in the development of Graves' disease by inducing SOCS mRNA m6A modification. Front Endocrinol (Lausanne). 2021;12:666393. doi: 10.3389/fendo.2021.666393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.666393</ArticleId><ArticleId IdType="pmc">PMC8488398</ArticleId><ArticleId IdType="pubmed">34616359</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem. 2011;57(2):168&#x2013;175. doi: 10.1373/clinchem.2010.148205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2010.148205</ArticleId><ArticleId IdType="pubmed">21127152</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Xu L, Luo S, et al. The m6A methylation profiles of immune cells in type 1 diabetes mellitus. Front Immunol. 2022;15(13):1030728. doi: 10.3389/fimmu.2022.1030728.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1030728</ArticleId><ArticleId IdType="pmc">PMC9707336</ArticleId><ArticleId IdType="pubmed">36457997</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Shen M, Ji C, et al. Genome-wide identification of N6-Methyladenosine associated SNPs as potential functional variants for type 1 diabetes. Front Endocrinol (Lausanne). 2022;13:913345. doi: 10.3389/fendo.2022.913345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.913345</ArticleId><ArticleId IdType="pmc">PMC9243540</ArticleId><ArticleId IdType="pubmed">35784577</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikanth V, Sinclair AJ, Hill-Briggs F, et al. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020;8(6):535&#x2013;545. doi: 10.1016/S2213-8587(20)30118-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30118-2</ArticleId><ArticleId IdType="pubmed">32445740</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc. 2021;1(4):e78. doi: 10.1002/cpz1.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpz1.78</ArticleId><ArticleId IdType="pubmed">33905609</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Zhong X, Zhao Z, et al. The expression of m6A enzymes in the hippocampus of diabetic cognitive impairment mice and the possible improvement of YTHDF1. Brain Res. 2022;1777:147766. doi: 10.1016/j.brainres.2021.147766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2021.147766</ArticleId><ArticleId IdType="pubmed">34953798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassmann H, van Horssen J, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol. 2012;8(11):647&#x2013;656. doi: 10.1038/nrneurol.2012.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.168</ArticleId><ArticleId IdType="pubmed">23007702</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye F, Wang T, Wu X, et al. N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis. J Transl Med. 2021;19(1):316. doi: 10.1186/s12967-021-02981-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02981-5</ArticleId><ArticleId IdType="pmc">PMC8296732</ArticleId><ArticleId IdType="pubmed">34294105</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo XB, Lei SF, Qian QY, et al. Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis. J Neurol. 2019;266(11):2699&#x2013;2709. doi: 10.1007/s00415-019-09476-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09476-w</ArticleId><ArticleId IdType="pubmed">31321514</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu CS, Farooqi N, O'Brien K, et al. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS) Br J Pharmacol. 2011;164(4):1079&#x2013;1106. doi: 10.1111/j.1476-5381.2011.01302.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2011.01302.x</ArticleId><ArticleId IdType="pmc">PMC3229753</ArticleId><ArticleId IdType="pubmed">21371012</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Zhang X, Hu J, et al. m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity. Sci Adv. 2021;7(25):eabg0470. doi: 10.1126/sciadv.abg0470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg0470</ArticleId><ArticleId IdType="pmc">PMC8208713</ArticleId><ArticleId IdType="pubmed">34134995</ArticleId></ArticleIdList></Reference><Reference><Citation>Catassi C, Verdu EF, Bai JC, et al. Coeliac disease. Lancet. 2022;399(10344):2413&#x2013;2426. doi: 10.1016/S0140-6736(22)00794-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00794-2</ArticleId><ArticleId IdType="pubmed">35691302</ArticleId></ArticleIdList></Reference><Reference><Citation>Olazagoitia-Garmendia A, Zhang L, Mera P, et al. Gluten-induced RNA methylation changes regulate intestinal inflammation via allele-specific XPO1 translation in epithelial cells. Gut. 2022;71(1):68&#x2013;76. doi: 10.1136/gutjnl-2020-322566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322566</ArticleId><ArticleId IdType="pmc">PMC8666699</ArticleId><ArticleId IdType="pubmed">33526437</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang S, Meng J, Tan J, et al. N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells. Clin Immunol. 2022;241:109080. doi: 10.1016/j.clim.2022.109080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.109080</ArticleId><ArticleId IdType="pubmed">35878734</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#x142;yszczuk P, Kozlova A, Guo Z, et al. Experimental mouse model of bleomycin-induced skin fibrosis. Curr Protoc Immunol. 2019;126(1):e88. doi: 10.1002/cpim.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpim.88</ArticleId><ArticleId IdType="pubmed">31483105</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L, Yu Y, Jiang M, et al. Alteration of the m6A methylation landscape in a mouse model of scleroderma. Epigenomics. 2021;13(23):1867&#x2013;1883. doi: 10.2217/epi-2021-0369.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/epi-2021-0369</ArticleId><ArticleId IdType="pubmed">34791892</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinwand J, Miller G. Regulation and modulation of antitumor immunity in pancreatic cancer. Nat Immunol. 2020;21(10):1152&#x2013;1159. doi: 10.1038/s41590-020-0761-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0761-y</ArticleId><ArticleId IdType="pubmed">32807942</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu Z, Huang B, Zhang J, et al. Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells. J Autoimmun. 2023;135:102993. doi: 10.1016/j.jaut.2023.102993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2023.102993</ArticleId><ArticleId IdType="pubmed">36642058</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia G, Fu Y, He C. Reversible RNA adenosine methylation in biological regulation. Trends Genet. 2013;29(2):108&#x2013;115. doi: 10.1016/j.tig.2012.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2012.11.003</ArticleId><ArticleId IdType="pmc">PMC3558665</ArticleId><ArticleId IdType="pubmed">23218460</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu Y, Zhao X, Wu YS, et al. N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics. 2013;11(1):8&#x2013;17. doi: 10.1016/j.gpb.2012.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gpb.2012.12.002</ArticleId><ArticleId IdType="pmc">PMC4357660</ArticleId><ArticleId IdType="pubmed">23453015</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler R, Gillis E, Lasman L, et al. m6A modification controls the innate immune response to infection by targeting type I interferons. Nat Immunol. 2019;20(2):173&#x2013;182. doi: 10.1038/s41590-018-0275-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0275-z</ArticleId><ArticleId IdType="pubmed">30559377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Dong J, Luo X, et al. Interaction between m6A and ncRNAs and its association with diseases. Cytogenet Genome Res. 2022;162(4):171&#x2013;187. doi: 10.1159/000526035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000526035</ArticleId><ArticleId IdType="pubmed">36122561</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YG, Chen R, Ahmad S, et al. N6-Methyladenosine Modification Controls Circular RNA Immunity. Mol Cell. 2019;76(1):96&#x2013;109.e9. doi: 10.1016/j.molcel.2019.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.07.016</ArticleId><ArticleId IdType="pmc">PMC6778039</ArticleId><ArticleId IdType="pubmed">31474572</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HB, Tong J, Zhu S, et al. m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways. Nature. 2017;548(7667):338&#x2013;342. doi: 10.1038/nature23450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23450</ArticleId><ArticleId IdType="pmc">PMC5729908</ArticleId><ArticleId IdType="pubmed">28792938</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>